We have observed
17 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
January 16, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
NEW PROCESS FOR THE SELECTIVE OXIDATION OF BILE ACIDS, THEIR SALTS OR DERIVATIVES
Process of catalytic partial oxidation
Controlled porous osmotic pump tablet and the preparation method thereof
NEW YEAST STRAINS AND USE THEREOF FOR THE CONTROL OF PHYTOPATHOGENIC FUNGI
Polymorphous form of sodium hyodeoxycholate (NaHDC) and preparation process thereof
CHEMOPREVENTION OF COLORECTAL CANCER
Food flours useful in the reduction of glycemia, in the treatment of metabolic syndrome, in the reduction of cholesterol and/or in the treatment of type 2 diabetes
PROCESS FOR THE PREPARATION OF AMINOARYL- AND AMINOHETEROARYL BORONIC ACIDS AND ESTERS
A METHOD FOR THE REINFORCEMENT OF NATURAL OR CONGLOMERATE STONE LIKE MATERIAL SLABS AND REINFORCED SLABS RESULTING
EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTIONING AND/OR ENDOSCOPIC SUBMUCOSAL DISSECTION.
SLOW-RELEASE SOLID ORAL COMPOSITIONS
CORTEXOLONE 17 -PROPIONATE FOR USE IN THE TREATMENT OF SKIN WOUNDS AND/OR ATROPHIC SKIN DISORDERS
TOPICAL COMPOSITION FOR USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
PROCESS FOR THE PURIFICATION OF L-ALPHA-GLYCEROPHOSPHORYLCHOLINE
AN INORGANIC BINDER SYSTEM FOR FOUNDRIES
PRODUCT BASED ON IRON BIS-GLYCINATE CHELATE AND ALGINIC ACID AND/OR WATER-SOLUBLE SALTS THEREOF, FORMULATIONS THEREOF, AND PHARMACEUTICAL USES THEREOF
HYDROXYETHYL SULFONATE OF CYCLIN-DEPENDENT PROTEIN KINASE INHIBITOR, CRYSTALLINE FORM THEREOF AND PREPARATION METHOD THEREFOR